About PPA   |   Contact Us   |   Report Abuse   |   Sign In   |   Join Now
CE Webinar: Saving Time & Saving Lives: Rapid Reversal of Oral Anticoagulants (New and Old)
Register Tell a Friend About This EventTell a Friend
CE Webinar: Saving Time & Saving Lives: Rapid Reversal of Oral Anticoagulants (New and Old)

Join us for this convenient online CE webinar!

 Export to Your Calendar 11/10/2016
When: Thursday, November 10, 2016
12 to 1 PM
Where: Webinar
Access instructions provided upon registration
United States
Presenter: Van Hellerslia, PharmD, BCPS, CACP
Contact: Sara Powers
(717) 234-6151 x. 2

Online registration is available until: 11/10/2016
« Go to Upcoming Event List  

Title: Saving Time & Saving Lives: Rapid Reversal of Oral Anticoagulants (New and Old)

Rapid anticoagulant reversal is warranted during life threatening bleeding or emergent surgery. Since reversal strategies vary in safety, onset, duration, and cost, it is recommended to have a plan in place so you are ready when this kind of emergency arises. This one hour webinar will equip pharmacists with the expertise needed to develop local protocols to promote the safe and effective use of reversal agents during life threatening situations relating to warfarin and the direct acting oral anticoagulants.


Van Hellerslia, PharmD, BCPS, CACP, Clinical Assistant Professor, Temple University School of Pharmacy

Dr. Hellerslia graduated from the University of the Sciences and completed a pharmacy practice residency at University of Wisconsin Hospital and Clinics in 2002. She has assumed various clinical leadership positions at local hospitals. For the past 7 years, she served as the Anticoagulation Specialist and Coordinator at Abington Health where she provided expertise to hematology, neurology, cardiology and surgery services in regards to thrombosis and hemostasis management. She is currently a Clinical Assistant Professor at Temple University School of Pharmacy and serves as the Clinical Pharmacy Specialist in the Neuro ICU at Temple University Health System.


Dr. Hellerslia has, in the past year, served as a paid consultant to Boehringer Ingelheim. However, her services were unrelated to the topic of this presentation and her role at Temple. Dr. Hellerslia has committed to presenting a program that is free of bias and influence.


Target Audience: Health System Pharmacists

CE Credit: 1 Contact Hour (0.1 CEUs)

Program Objectives:

At the completion of this activity, the participant will be able to
1. Describe the clinical indications that would require rapid oral anticoagulation reversal
2. List the agents used for rapid warfarin reversal
3. Summarize the differences between prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) in safety, efficacy, and cost for rapid warfarin reversal
4. Summarize the spectrum and anticoagulant reversal activity of idarucizumab, andexanet and aripazine as it relates to the direct acting oral anticoagulants
5. Design a treatment and monitoring plan for a patient requiring emergent dabigatran reversal
Schedule: 11:55 AM to 12:00 PM - Attendees log in
12:00 to 1:00 PM - CE Program
Activity Type: Application-based
Cost: PPA Members - Free
Non-Members - $30
   *Requests for cancellation refunds must be submitted to PPA at least one day in advance of the webinar. All refunds will be subject to a $5 administrative fee.
UAN: 0159-0000-16-033-L01-P
Requirements to receive credit: Participants must attend the entire program and complete an online evaluation survey within one week. PPA must have your CPE Monitor ID and birthday on file to issue credit.


To Register:

Use the link above to register for this program. 

Click here to view current software requirements

The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Association Management Software Powered by YourMembership.com®  ::  Legal